Simon LF Walsh
Chief Scientific Officer Qureight
Seminars
Wednesday 20th August 2025
Imaging-Based Machine Learning in Fibrotic Lung Disease: A Platform for Precision Medicine and Trial Deployment
5:00 pm
- A presentation of deep learning-based imaging biomarkers that predict clinical outcomes, enrich trial cohorts, and track treatment response in interstitial lung disease
- Explore advanced applications, including the use of imaging-derived data to support synthetic control arms and accelerate therapeutic development
- Describe our platform and deployment methods used to match patients to trial eligibility criteria and integrate imaging biomarkers into clinical research workflows
